A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT07040059 · TERMINATED

Trial details

NCT number: NCT07040059
Sponsor: Aurigene Discovery Technologies Limited
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER 2 Positive Gastric Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2025-03-22
Primary completion: 2025-12-29
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.